We are committed to finding a cure for WM.

Verizon IndyCar Series driver James Hinchcliffe helps family compete against WM

Four-time Verizon IndyCar Series race winner James Hinchcliffe will return to the Verizon IndyCar Series in 2016 after a life threatening accident in 2015. James continues to support the Waldenstrom’s Macroglobulinemia Foundation of Canada, which was founded by his mother Arlene after her own father passed away from the rare blood cancer.


James Hinchcliffe - Photo by Brian Lawdermilk

James Hinchcliffe –
Photo by Brian Lawdermilk

“As a family we know only too well the effects of this disease,” stated Hinchcliffe. “I’m always in awe of my mom’s passion to not only raise awareness of Waldenstrom’s Macroglobulinema but her tireless efforts through the WMFC to fund research into it so we can better understand it.”
James Hinchcliffe has donated several items including his race suit from an Indy 500, where he qualified on the front-row for the second time in three seasons, as well as various race car parts and some of his own famed “Hinchtown Hammer Down” ale for fundraising events.
James will start the 2016 season with Schmidt Peterson Motorsports in the #5 Arrow Electronics Honda powered IndyCar. After winning ‘Rookie of the Year’ honors in 2011, he twice finished inside the top-10 driver standings with 4 victories and 7 podium finishes competing in North America’s premier open-wheel racing series.
“I’m hoping some of my items will help bolster the money raised and I’d encourage everyone to check out the WMFC website for details. The ‘Imagine A Cure’ campaign has a goal of raising $1million within five years , by 2019, to fund more research into the disease. Currently WMFC is funding a two-year research project at the British Columbia Cancer Agency in Vancouver.
Note: WM (aka lymphoplasmacytic lymphoma) is a rare disease affecting B cells (a type of white bloodcells formed in the bone marrow and lymph nodes). Symptoms include weakness, fatigue, weight loss and chronic oozing of blood from the nose and gums, as well as blurriy vision and/or loss of eyesight, headaches and (in rare cases) stroke or coma. In addition about 10% of patients have been diagnosed with pPeripheral neuropathy, while 30-40% of patients may suffer from lymphadenopathy, splenomegaly, and/or hepatomegaly. The disease is currently found in less than 1,500 people in the US. While the median onset age is between 60-65, some cases have been diagnosed in late teens. Although there is no cure, many people are able to live active lives with treatment.